Are leukotrienes or PAF involved in hyperbaric oxygen toxicity?
- Publication Type:
- Journal Article
- Citation:
- Agents and Actions, 1993, 38 (1 Supplement), pp. 66 - 75
- Issue Date:
- 1993-01-01
Closed Access
| Filename | Description | Size | |||
|---|---|---|---|---|---|
| 1993 Are leukotrienes or PAF involved in hyperbaric oxygen toxicity.pdf | Published Version | 708.77 kB |
Copyright Clearance Process
- Recently Added
- In Progress
- Closed Access
This item is closed access and not available.
Several very selective leukotriene inhibitors, and a PAF inhibitor, suitable for in vivo use, have been tested for their effects on hyperbaric oxygen toxicity. The leukotriene D4 inhibitor, L660 771, and the 5-lipoxygenase pathway inhibitor L663 563, failed to affect convulsions or lung damage induced by hyperbaric oxygen (pressure range 515-615 kPa) in either rats or mice. The specific PAF antagonist L659 989 showed marginal protection against hyperoxic convulsions and did not alter pulmonary damage. The specific LTB4 antagonist SC-41930 was very effective in inhibiting hyperbaric oxygen-induced convulsions in both rats and mice. SC-41930 also very significantly protected rats against pulmonary oxygen toxicity, but had only marginally significant effects on pulmonary protection in mice. © 1993 Birkhäuser Verlag.
Please use this identifier to cite or link to this item: